ProfileGDS4132 / 217553_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 42% 44% 44% 37% 43% 39% 40% 41% 31% 37% 37% 35% 37% 42% 38% 35% 40% 28% 30% 33% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 101110.7542
GSM201543Muscle PCOS pioglitazone 121108.41444
GSM201544Muscle PCOS pioglitazone 161118.61744
GSM201545Muscle PCOS pioglitazone 201101.41637
GSM201829Muscle PCOS pioglitazone 231120.6843
GSM201830Muscle PCOS pioglitazon 251104.74939
GSM201831Muscle PCOS pioglitazone 271104.21240
GSM201832Muscle PCOS pioglitazone 31104.05841
GSM201833Muscle PCOS pioglitazone 4173.689331
GSM201834Muscle PCOS pioglitazone 8191.137537
GSM201835Muscle PCOS after pioglitazone 10280.662537
GSM201836Muscle PCOS after pioglitazone 12276.742735
GSM201837Muscle PCOS after pioglitazone 16280.006937
GSM201838Muscle PCOS after pioglitazone 20299.843842
GSM201839Muscle PCOS after pioglitazone 23289.183738
GSM201840Muscle PCOS after pioglitazone 25285.622735
GSM201841Muscle PCOS after pioglitazone 27287.247240
GSM201842Muscle PCOS after pioglitazone 3254.612128
GSM201843Muscle PCOS after pioglitazone 4273.244230
GSM201844Muscle PCOS after pioglitazone 8276.236433